• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型 Braile Inovare 经导管主动脉瓣假体:临床结果和随访。

New Braile Inovare transcatheter aortic prosthesis: clinical results and follow-up.

机构信息

Cardiovascular Surgery Department, Federal University of São Paulo, São Paulo, Brazil.

出版信息

EuroIntervention. 2015 Oct;11(6):682-9. doi: 10.4244/EIJV11I6A136.

DOI:10.4244/EIJV11I6A136
PMID:26499221
Abstract

AIMS

Transcatheter aortic valve implantation has emerged as an alternative to conventional aortic valve replacement in high-risk patients. Diverse prostheses are currently under investigation. The aim of this study was the clinical, safety and efficacy assessment of Braile Inovare Transcatheter Aortic Prosthesis usage.

METHODS AND RESULTS

Ninety high-risk or inoperable patients underwent transcatheter aortic valve implantation. The mean logistic EuroSCORE was 39.3%. All patients presented calcified aortic stenosis. The procedures were performed under fluoroscopic and echocardiographic guidance. Prostheses were implanted through the transapical approach under rapid ventricular pacing. Echocardiographic and angiographic controls were included. Implantation was feasible in 87 cases. There was only one case of operative mortality, and 30-day mortality was 13.3%. The median transvalvular aortic gradient was reduced from 44.8±15.3 to 14.1±8.0 mmHg. Left ventricular function improved in the first seven postoperative days. Paravalvular aortic regurgitation was present in 29.7% of cases, mostly trace. One case presented a major vascular complication, and there were two cases of permanent pacemaker implantation. Two cases of major stroke occurred.

CONCLUSIONS

Transcatheter aortic valve replacement using the Braile Inovare prosthesis is able to provide encouraging results with significant functional and structural cardiac improvement. It is mandatory to continue follow-up to measure the benefits of this device as well as to improve selection criteria of patients.

摘要

目的

经导管主动脉瓣置换术已成为高危患者传统主动脉瓣置换术的替代方法。目前正在研究多种假体。本研究的目的是评估 Braile Inovare 经导管主动脉瓣假体使用的临床、安全性和疗效。

方法和结果

90 例高危或不能手术的患者接受了经导管主动脉瓣植入术。平均逻辑 EuroSCORE 为 39.3%。所有患者均有钙化性主动脉瓣狭窄。手术在透视和超声心动图引导下进行。假体通过经心尖途径在快速心室起搏下植入。包括超声心动图和血管造影检查。87 例手术可行。只有 1 例手术死亡,30 天死亡率为 13.3%。跨瓣主动脉梯度从 44.8±15.3mmHg 降至 14.1±8.0mmHg。左心室功能在术后 7 天内得到改善。瓣周主动脉瓣反流发生率为 29.7%,大多为微量。1 例发生主要血管并发症,2 例植入永久性起搏器。发生 2 例主要卒中。

结论

使用 Braile Inovare 假体进行经导管主动脉瓣置换术能够提供令人鼓舞的结果,显著改善心功能和结构。必须继续随访,以衡量该器械的益处,并改进患者的选择标准。

相似文献

1
New Braile Inovare transcatheter aortic prosthesis: clinical results and follow-up.新型 Braile Inovare 经导管主动脉瓣假体:临床结果和随访。
EuroIntervention. 2015 Oct;11(6):682-9. doi: 10.4244/EIJV11I6A136.
2
1-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results of the REPRISE II Study.120例严重主动脉瓣狭窄高危手术患者使用可完全重新定位和回收的Lotus经导管主动脉瓣置换瓣膜的1年结局:REPRISE II研究结果
JACC Cardiovasc Interv. 2016 Feb 22;9(4):376-384. doi: 10.1016/j.jcin.2015.10.024.
3
Impact of aortic valve calcification on the outcome of transcatheter aortic valve implantation: results from the prospective multicenter German TAVI registry.主动脉瓣钙化对经导管主动脉瓣植入术结果的影响:前瞻性多中心德国 TAVI 注册研究结果。
Catheter Cardiovasc Interv. 2013 Feb;81(2):348-55. doi: 10.1002/ccd.24332. Epub 2012 May 4.
4
Prospective Multicenter Evaluation of the Direct Flow Medical Transcatheter Aortic Valve System: 12-Month Outcomes of the Evaluation of the Direct Flow Medical Percutaneous Aortic Valve 18F System for the Treatment of Patients With Severe Aortic Stenosis (DISCOVER) Study.直接血流经导管主动脉瓣系统的前瞻性多中心评估:经皮主动脉瓣 18F 系统治疗严重主动脉瓣狭窄患者的直接血流医学评估 18 个月的结果(DISCOVER)研究。
JACC Cardiovasc Interv. 2016 Jan 11;9(1):68-75. doi: 10.1016/j.jcin.2015.09.027.
5
Transcatheter aortic valve implantation without balloon predilation: a single-center pilot experience.经导管主动脉瓣植入术无球囊预扩张:单中心初步经验。
Catheter Cardiovasc Interv. 2013 Aug 1;82(2):292-7. doi: 10.1002/ccd.24805. Epub 2013 Apr 18.
6
Transapical transcatheter aortic valve implantation: follow-up to 3 years.经心尖入路经导管主动脉瓣植入术:3 年随访结果。
J Thorac Cardiovasc Surg. 2010 May;139(5):1107-13, 1113.e1. doi: 10.1016/j.jtcvs.2009.10.056.
7
Outcomes with post-dilation following transcatheter aortic valve replacement: the PARTNER I trial (placement of aortic transcatheter valve).经导管主动脉瓣置换术后的扩张效果:PARTNER I 试验(主动脉经导管瓣膜置换术)。
JACC Cardiovasc Interv. 2014 Jul;7(7):781-9. doi: 10.1016/j.jcin.2014.02.013.
8
Transcatheter aortic valve implantation: results of the current development and implantation of a new Brazilian prosthesis.经导管主动脉瓣植入术:一种新型巴西人工瓣膜的当前研发及植入结果
Rev Bras Cir Cardiovasc. 2011 Jul-Sep;26(3):338-47. doi: 10.5935/1678-9741.20110007.
9
Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries.北欧国家经导管主动脉瓣中瓣植入术的早期临床结果。
J Thorac Cardiovasc Surg. 2013 Nov;146(5):1047-54; discussion 1054. doi: 10.1016/j.jtcvs.2013.06.045. Epub 2013 Aug 30.
10
Clinical impact of aortic regurgitation after transcatheter aortic valve replacement: insights into the degree and acuteness of presentation.经导管主动脉瓣置换术后主动脉瓣反流的临床影响:对病变程度和发病急缓的深入了解。
JACC Cardiovasc Interv. 2014 Sep;7(9):1022-32. doi: 10.1016/j.jcin.2014.04.012.

引用本文的文献

1
A European update on transcatheter aortic valve implantation (TAVI) in the COVID era.欧洲在新冠疫情时代经导管主动脉瓣植入术(TAVI)的最新进展。
J Anat. 2023 Jan;242(1):50-63. doi: 10.1111/joa.13740. Epub 2022 Sep 24.
2
Early multicenter experience of a new balloon expandable MyVal transcatheter heart valve in dysfunctional stenosed right ventricular outflow tract conduits.新型球囊扩张式MyVal经导管心脏瓣膜用于功能失调性狭窄右心室流出道管道的早期多中心经验。
Ann Pediatr Cardiol. 2021 Jul-Sep;14(3):293-301. doi: 10.4103/apc.apc_242_20. Epub 2021 Aug 26.
3
First-in-Human Endo-Bentall Procedure for Simultaneous Treatment of the Ascending Aorta and Aortic Valve.
首例用于同时治疗升主动脉和主动脉瓣的人体内置Bentall手术
JACC Case Rep. 2020 Feb 12;2(3):480-485. doi: 10.1016/j.jaccas.2019.11.071. eCollection 2020 Mar.
4
Relationship between Mitral Regurgitation and Transcatheter Aortic Valve Implantation: a Multi-Institutional Follow-up Study.二尖瓣反流与经导管主动脉瓣植入术的关系:一项多机构随访研究。
Arq Bras Cardiol. 2021 Jun;116(6):1059-1069. doi: 10.36660/abc.20190772.
5
Patient-specific in vitro testing for evaluating TAVR clinical performance-A complementary approach to current ISO standard testing.用于评估 TAVR 临床性能的患者特异性体外测试——对当前 ISO 标准测试的补充方法。
Artif Organs. 2021 Apr;45(4):E41-E52. doi: 10.1111/aor.13841. Epub 2020 Dec 7.
6
Hemodynamic and Imaging Assessment of Transcatheter Aortic Valve Replacement with the Inovare® Proseal using Multislice Computed Tomography.使用多层计算机断层扫描对Inovare® Proseal经导管主动脉瓣置换术进行血流动力学和影像学评估。
Braz J Cardiovasc Surg. 2020 Apr 1;35(2):127-133. doi: 10.21470/1678-9741-2019-0103.
7
Thrombocytopenia After Transcatheter Valve-in-Valve Implantation: Prognostic Marker or Mere Finding?经导管瓣中瓣植入术后血小板减少症:是预后标志物还是单纯的发现?
Braz J Cardiovasc Surg. 2018 Jul-Aug;33(4):362-370. doi: 10.21470/1678-9741-2018-0078.
8
Realistic Vascular Replicator for TAVR Procedures.用于经导管主动脉瓣置换术的逼真血管复制器。
Cardiovasc Eng Technol. 2018 Sep;9(3):339-350. doi: 10.1007/s13239-018-0356-z. Epub 2018 Apr 13.
9
Combined Mitral and Aortic Valvar Bioprosthesis Transcatheter Transapical Implant: First Description in Brazil.经导管经心尖联合二尖瓣和主动脉瓣生物瓣膜植入术:巴西首例报道
Arq Bras Cardiol. 2017 Nov;109(5):491-494. doi: 10.5935/abc.20170118.
10
Matching patients with the ever-expanding range of TAVI devices.为不断扩大的 TAVI 设备范围的患者进行匹配。
Nat Rev Cardiol. 2017 Oct;14(10):615-626. doi: 10.1038/nrcardio.2017.82. Epub 2017 Jul 6.